Literature DB >> 24719932

Does resection of primary lesions show survival benefit for stage IV colorectal cancer patients with unresectable metastases?

Yasushi Ichikawa, Ayumu Goto, Noritoshi Kobayashi, Mitsuyoshi Ota, Motohiko Tokuhisa, Atsushi Ishibez, Jun Watanabe, Kazuteru Watanabe, Takashi Ishikawa, Kuniya Tanaka, Hirotoshi Akiyama, Shoichi Fujii, Itaru Endo.   

Abstract

BACKGROUND/AIMS: The aims of the current retrospective cohort study were to compare OS of the primary resection (R-g) and the non-resection group (NR-g) after 2005.
METHODOLOGY: Ninety-five patients with stage IV colorectal cancer with unresectable distant metastases were divided into 2 groups; R-g; 37 and NR-g; 58.
RESULTS: The only significant difference in clinical factors between the 2 was R0 resection rate (p = 0.007). The MST in R-g was superior to that in NR-g, 30.7 vs. 21.9 months (p = 0.031). After excluding the patients that underwent R0 resection, there was no difference in OS between the 2; however, the MST was 28.6 months in R-g and 17.1 months in NR-g.
CONCLUSIONS: The advantage of resection of the primary is still unclear and a well-designed randomized Phase III study is expected. However, the current results suggest that resection of the primary lesion before intensive chemotherapy had some benefit for prognosis.

Entities:  

Mesh:

Year:  2013        PMID: 24719932

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Constantinos Simillis; Eliana Kalakouti; Thalia Afxentiou; Christos Kontovounisios; Jason J Smith; David Cunningham; Michel Adamina; Paris P Tekkis
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

2.  Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?

Authors:  Narimantas E Samalavicius; Audrius Dulskas; Edita Baltruskeviciene; Giedre Smailyte; Marija Skuciene; Rasa Mikelenaite; Rasa Venslovaite; Eduardas Aleknavicius; Almantas Samalavicius; Raimundas Lunevicius
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2016-12-31       Impact factor: 1.195

3.  Nomogram to Predict the Occurrence and Prognosis of Distant Metastasis in T1N0 Colon Cancer: A SEER Data-Based Study.

Authors:  Yunxiao Liu; Hao Zhang; Mingyu Zheng; Chunlin Wang; Zhiqiao Hu; Yang Wang; Huan Xiong; BoYang Fan; Yuliuming Wang; Hanqing Hu; Qingchao Tang; Guiyu Wang
Journal:  Int J Gen Med       Date:  2021-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.